*Check the background of this investment professional on FINRA's BrokerCheck »
I’m Kristine Dorward
I leverage my experience in corporate and business development to help clients achieve their partnering goals. Prior to joining Pullan Consulting I held roles in the pharma/biotech industry focused on licensing, asset acquisitions, strategic planning and commercial launch strategy.
Kristine@pullanconsulting.com
+1-514-618-0360
I’m Trevor Thompson
I work with clients to align strategy and operations with their financing and partnering goals. Prior to consulting, I was VP of Corporate Development for a therapeutic antibody company. Trevor Thompson is also an investment banker registered with Finalis Securities LLC a member of FINRA/SIPC.
+1-805-279-2337
We can work on a simple hourly basis with no minimums, by retainer or by the project.
*Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Pullan Consulting is not a registered broker-dealer, and Finalis Securities LLC and Pullan Consulting are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck
I’m Eric Hayes
I bring 30 years of experience in drug discovery and development leading to marketed products to help clients build and select assets with value. Previous roles at BioCurate Pty Ltd, Porsolt SAS, Astrum Therapeutics Pty Ltd and Cardiome Pharma Corp. are the foundation of my passion for getting therapeutics to patients.
+61-488012470
I’m Linda Pullan
I’ve been helping with biotech partnering for years, and I love it. Before I was in consulting, I was in licensing or business development at Amgen, AstraZeneca and Kosan, and in drug discovery research, after a PhD in biochemistry.
Linda@pullanconsulting.com
+1-805-558-0361